Skip to main content

Table 3 Comparison between cases with and without CTRCD regarding ECHO parameters at baseline

From: Two-dimensional speckle tracking echocardiography in chemotherapy-induced cardiotoxicity in females with breast cancer

Baseline

Without CTRCD

With CTRCD

Test value

P-value

Sig

No. = 70

No. = 24

LVEDD

Mean ± SD

47.14 ± 4.12

48.42 ± 3.59

-1.348b

0.181

NS

Range

39 – 55

44 – 56

LVESD

Mean ± SD

30.73 ± 3.25

32.67 ± 3.23

-2.527b

0.013

S

Range

23 – 37

28 – 40

LA AP diameter

Mean ± SD

35.59 ± 4.11

35.96 ± 2.77

-0.412b

0.681

NS

Range

26 – 45

30 – 42

Diastolic function

Normal

16 (22.9%)

1 (4.2%)

4.214a

0.040

S

Grade I

54 (77.1%)

23 (95.8%)

Grade II

0 (0.0%)

0 (0.0%)

Grade III

0 (0.0%)

0 (0.0%)

EF by M-mode

Mean ± SD

63.67 ± 3.94

61.29 ± 3.28

2.660b

0.009

HS

Range

58 – 74

54 – 68

EF by Simpson’s method

Mean ± SD

60.21 ± 2.80

59.29 ± 3.50

1.304b

0.195

NS

Range

52 – 68

53 – 68

RV S’

Mean ± SD

12.89 ± 0.86

12.42 ± 0.83

2.325b

0.022

S

Range

11 – 15

11 – 14

GLS %

Mean ± SD

-18.85 ± 1.56

-17.58 ± 1.28

-3.603b

0.001

HS

Range

-22 – -16

-21 – -16

GCS %

Mean ± SD

-24.34 ± 1.77

-23.21 ± 1.86

-2.647b

0.010

S

Range

-27.6 – -21

-26.6 – -20.9

GRS %

Mean ± SD

45.91 ± 6.55

43.76 ± 6.83

1.370b

0.174

NS

Range

33.8 – 58.8

37.2 – 55.2

RVGLS %

Mean ± SD

-23.20 ± 1.04

-22.68 ± 0.92

-2.170b

0.033

S

Range

-27 – -21.6

-25 – -21.6

RV FWLS %

Mean ± SD

-25.47 ± 1.20

-24.83 ± 0.96

-2.354b

0.021

S

Range

-30 – -23

-27 – -23

  1. aChi-square test
  2. bIndependent t-test